Zhenhan Deng | Medicine and Dentistry | Best Researcher Award

Published on by Global Academic Awards

Zhenhan Deng | Medicine and Dentistry | Best Researcher Award

Dr Zhenhan Deng, The First Affiliated Hospital of Wenzhou Medical University, China

Dr. Zhenhan Deng is a distinguished orthopedic surgeon born on July 19, 1989. He currently serves as a Deputy Chief Physician at The First Affiliated Hospital of Wenzhou Medical University in China 🇨🇳. Dr. Deng completed his Ph.D. at Xiangya Hospital, CSU, and was a visiting scholar at the University of Texas Health Science Center 🏥. His research focuses on osteoarthritis and cartilage regeneration, supported by significant grants and notable publications 📚. He has received multiple awards, including the Orthopaedic Research Society’s New Investigator Recognition Award and the Shenzhen Health Elite Talent title 🌟. For more details, visit his official website 🌐.

Publication profile

google scholar

Education

Deng pursued his Ph.D. in Orthopedics at Xiangya Hospital, Central South University (CSU), Hunan, China, from September 2015 to November 2018. Additionally, he was a Visiting Scholar at the University of Texas Health Science Center at Houston, focusing on Orthopedics, from December 2016 to September 2018. Prior to his doctoral studies, Deng completed his Master of Medicine and Bachelor of Medicine degrees at Xiangya Hospital, CSU.

Work Experience

Throughout his career, Deng has held various positions in orthopedic surgery and sports medicine. He served as a Deputy Chief Physician in the Department of Orthopedic Surgery at The First Affiliated Hospital of Wenzhou Medical University from December 2023 to September 2023. Prior to this, he worked as an Attending Physician in the same department. Deng also gained experience as an Attending Physician in the Department of Sports Medicine at Shenzhen Second People’s Hospital, Shenzhen, Guangdong, China, from September 2020 to September 2023, after starting as a Resident Physician in December 2018.

Awards

Deng has received numerous awards and honors for his contributions to orthopedic research and clinical practice. Notable accolades include being nominated for the Orthopaedic Research Society (ORS) New Investigator Recognition Awards (NIRA), winning the Orthopaedic Research Society (ORS) ON Foundation/ORS Orthoregeneration Award, and receiving recognition as an Outstanding Graduate of Hunan Province.

Research focus

Zhenhan Deng is an orthopaedic surgeon and researcher focused on advancing treatments for musculoskeletal conditions, particularly osteoarthritis and cartilage repair. His research encompasses the development of innovative therapies, such as microgel scaffolds, mesenchymal stem cells, and gene therapy to promote cartilage regeneration and joint repair. Deng’s work includes investigating the roles of various signaling pathways in disease progression and treatment efficacy. His projects and publications underscore his commitment to improving patient outcomes through cutting-edge, translational medical research. 🩺🦴🧬🔬💡🌟

For further information, you can visit his personal work website at https://dzhdr.haodf.com/.

Publication top notes

  1. Electrical stimulation for pain relief in knee osteoarthritis: systematic review and network meta-analysis
    C Zeng, T Yang, Z Deng, Y Yang, Y Zhang, G Lei
    Osteoarthritis and Cartilage, 2015 – 179 citations 📊
  2. Effectiveness of continuous and pulsed ultrasound for the management of knee osteoarthritis: a systematic review and network meta-analysis
    C Zeng, H Li, T Yang, ZH Deng, Y Yang, Y Zhang, X Ding, GH Lei
    Osteoarthritis and Cartilage, 2014 – 158 citations 📉
  3. Macrophages in osteoarthritis: pathophysiology and therapeutics
    Y Chen, W Jiang, H Yong, M He, Y Yang, Z Deng, Y Li
    American Journal of Translational Research, 2020 – 118 citations 🦠
  4. Bone morphogenetic proteins for articular cartilage regeneration
    ZH Deng, YS Li, X Gao, GH Lei, J Huard
    Osteoarthritis and Cartilage, 2018 – 103 citations 💉
  5. The role of sirtuin 1 and its activator, resveratrol in osteoarthritis
    Z Deng, Y Li, H Liu, S Xiao, L Li, J Tian, C Cheng, G Zhang, F Zhang
    Bioscience Reports, 2019 – 97 citations 🍇
  6. Long noncoding RNAs in osteoarthritis
    J Lu, Z Deng, Y Li, G Lei
    Joint Bone Spine, 2017 – 88 citations 🧬
  7. Cartilage tissue engineering: From proinflammatory and anti‑inflammatory cytokines to osteoarthritis treatments
    S Liu, Z Deng, K Chen, S Jian, F Zhou, Y Yang, Z Fu, H Xie, J Xiong, …
    Molecular Medicine Reports, 2022 – 86 citations 🦴
  8. Is posterior tibial slope associated with noncontact anterior cruciate ligament injury?
    C Zeng, T Yang, S Wu, S Gao, H Li, Z Deng, Y Zhang, G Lei
    Knee Surgery, Sports Traumatology, Arthroscopy, 2016 – 81 citations 🏃‍♂️
  9. Characterization of a novel polyvinyl alcohol/chitosan porous hydrogel combined with bone marrow mesenchymal stem cells and its application in articular cartilage repair
    L Peng, Y Zhou, W Lu, W Zhu, Y Li, K Chen, G Zhang, J Xu, Z Deng, …
    BMC Musculoskeletal Disorders, 2019 – 73 citations 💧
  10. Association between dietary magnesium intake and radiographic knee osteoarthritis
    C Zeng, H Li, J Wei, T Yang, Z Deng, Y Yang, Y Zhang, T Yang, G Lei
    PLoS One, 2015 – 70 citations 🍽️
  11. RhoA/ROCK pathway: implication in osteoarthritis and therapeutic targets
    Z Deng, Y Jia, H Liu, M He, Y Yang, W Xiao, Y Li
    American Journal of Translational Research, 2019 – 67 citations 🔬
  12. MALAT1 promotes osteosarcoma development by targeting TGFA via MIR376A
    W Luo, H He, W Xiao, Q Liu, Z Deng, Y Lu, Q Wang, Q Zheng, Y Li
    Oncotarget, 2016 – 65 citations 🎯
  13. Alterations of amino acid metabolism in osteoarthritis: its implications for nutrition and health
    Y Li, W Xiao, W Luo, C Zeng, Z Deng, W Ren, G Wu, G Lei
    Amino Acids, 2016 – 63 citations 🍽️
  14. Modified arthroscopic Latarjet procedure: suture-button fixation achieves excellent remodeling at 3-year follow-up
    J Xu, H Liu, W Lu, Z Deng, W Zhu, L Peng, K Ouyang, H Li, D Wang
    The American Journal of Sports Medicine, 2020 – 58 citations 🏅
  15. MicroRNA-199a-5p inhibits cisplatin-induced drug resistance via inhibition of autophagy in osteosarcoma cells
    Y Li, W Jiang, Y Hu, Z Da, C Zeng, M Tu, Z Deng, W Xiao
    Oncology Letters, 2016 – 53 citations 🚫
  16. MicroRNA-379 inhibits the proliferation, migration and invasion of human osteosarcoma cells by targetting EIF4G2
    X Xie, YS Li, WF Xiao, ZH Deng, HB He, Q Liu, W Luo
    Bioscience Reports, 2017 – 51 citations 🛡️
  17. MicroRNA-127-5p regulates osteopontin expression and osteopontin-mediated proliferation of human chondrocytes
    M Tu, Y Li, C Zeng, Z Deng, S Gao, W Xiao, W Luo, W Jiang, L Li, G Lei
    Scientific Reports, 2016 – 50 citations 🧫
  18. p38MAPK signaling pathway in osteoarthritis: pathological and therapeutic aspects
    Z Li, A Dai, M Yang, S Chen, Z Deng, L Li
    Journal of Inflammation Research, 2022 – 45 citations 🌡️
  19. Diet-intestinal microbiota axis in osteoarthritis: a possible role
    Y Li, W Luo, Z Deng, G Lei
    Mediators of Inflammation, 2016 – 45 citations 🔗
  20. Relationship between cigarette smoking and radiographic knee osteoarthritis in Chinese population: a cross-sectional study
    Y Zhang, C Zeng, H Li, T Yang, Z Deng, Y Yang, X Ding, D Xie, Y Wang, …
    Rheumatology International, 2015 – 45 citations 🚬

Each line provides the title of the paper, the authors, the journal it was published in, the year of publication, the number of citations, and an emoji representing the general theme or content of the paper.

Erica Pietroluongo | Medicine | Young Scientist Award

Published on by Global Academic Awards

Dr. Erica Pietroluongo | Medicine | Young Scientist Award

Dr. Erica Pietroluongo, University of Naples Federico II, Italy

👩‍⚕️ Dr. Erica Pietroluongo is a dedicated oncologist and researcher based in Naples, Italy. With an MD from the University of Naples Federico II and ongoing PhD studies in Advanced Biomedical and Surgical Therapies, she specializes in medical oncology, particularly in rare tumors. Dr. Pietroluongo is actively involved in various professional societies, including the American Society of Clinical Oncology and the International Thymic Malignancy Working Group. Her research focuses on improving treatment personalization in breast cancer and investigating bioumoral determinants in SARS-Cov-2-infected patients with thymic epithelial tumors. She also contributes to teaching and training future medical professionals.

Publication Profile:

Scopus

Orcid

Education:

📚 Dr. Erica Pietroluongo pursued her passion for medicine at the University of Naples Federico II, where she earned her MD in Medicine. With a strong foundation in healthcare, she embarked on a journey of continuous learning, currently immersing herself in the realm of research as a PhD student in Advanced Biomedical and Surgical Therapies. Under the guidance of Prof. F Pane at the Department of Clinical Medicine and Surgery, University of Naples Federico II, she delves into cutting-edge studies. 🎓 Committed to advancing medical knowledge, Dr. Pietroluongo’s dual roles as a physician and researcher epitomize her dedication to enhancing patient care and outcomes.

Teaching and Training:

📝 Dr. Erica Pietroluongo is deeply committed to advancing her skills in clinical research and teaching methodologies. In April 2023, she participated in a Medical Writing Course organized by the Italian Society of Surgery in Campobasso, in collaboration with prestigious institutions like Springer Nature and the University of Naples Federico II. This course equipped her with essential writing skills vital for disseminating research findings effectively. Moreover, in June 2023, she further honed her expertise as an “Expert in Evaluation and Facilitation of Regional Oncology Networks” through a program facilitated by AGENAS, the National Agency for Health Regional Services. 🌟 These training initiatives underscore Dr. Pietroluongo’s commitment to enhancing her capabilities and contributing to the advancement of healthcare practices.

Research Focus:

🔍 Dr. Erica Pietroluongo’s research focus primarily revolves around two key areas: thymic epithelial tumors and breast cancer. In her studies on thymic epithelial tumors, she explores the impact of SARS-Cov-2 mRNA vaccines on patients’ immune responses and seroconversion. Additionally, she investigates the potential diagnostic role of miRNAs in breast cancer, particularly miRNA-27a and miRNA-128, packaged in extracellular vesicles. Her work not only sheds light on the immunological responses to COVID-19 vaccines in cancer patients but also aims to identify novel biomarkers for improved diagnosis and prognosis in breast cancer. Dr. Pietroluongo’s research contributes significantly to both oncology and immunology fields. 🎯

Publication Top Notes:

Serum biomarkers of inflammation and vascular damage upon SARS-Cov-2 mRNA vaccine in patients with thymic epithelial tumors

miRNAs in the Box: Potential Diagnostic Role for Extracellular Vesicle-Packaged miRNA-27a and miRNA-128 in Breast Cancer

Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors